Michael P. Thomas

2.4k total citations
5 papers, 385 citations indexed

About

Michael P. Thomas is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Michael P. Thomas has authored 5 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Cancer Research and 1 paper in Oncology. Recurrent topics in Michael P. Thomas's work include Ubiquitin and proteasome pathways (3 papers), NF-κB Signaling Pathways (2 papers) and RNA Interference and Gene Delivery (1 paper). Michael P. Thomas is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), NF-κB Signaling Pathways (2 papers) and RNA Interference and Gene Delivery (1 paper). Michael P. Thomas collaborates with scholars based in United States, India and Canada. Michael P. Thomas's co-authors include Lawrence R. Dick, Teresa A. Soucy, Michael A. Milhollen, Mark Manfredi, Usha Narayanan, Louis M. Staudt, Tary Traore, Lenny Dang, Jie Yu and Joseph B. Bolen and has published in prestigious journals such as Blood, Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Michael P. Thomas

4 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael P. Thomas United States	4	334	153	68	51	38	5	385
Tary Traore United States	4	262 0.8×	124 0.8×	51 0.8×	40 0.8×	37 1.0×	11	315
Britta Lamottke Germany	7	300 0.9×	151 1.0×	48 0.7×	33 0.6×	105 2.8×	8	420
Peggy Masdehors France	9	447 1.3×	212 1.4×	54 0.8×	55 1.1×	41 1.1×	11	523
Sreedhar Venkannagari United States	6	341 1.0×	97 0.6×	36 0.5×	57 1.1×	20 0.5×	8	415
Danielle N. Yarde United States	8	232 0.7×	140 0.9×	47 0.7×	26 0.5×	25 0.7×	11	386
Janice M. Mehnert United States	8	303 0.9×	183 1.2×	58 0.9×	26 0.5×	40 1.1×	24	409
Luana D’Artista Italy	7	414 1.2×	228 1.5×	54 0.8×	22 0.4×	32 0.8×	9	496
Ildiko Grandal Canada	6	260 0.8×	190 1.2×	61 0.9×	15 0.3×	39 1.0×	10	376
J Y J Wang United States	9	255 0.8×	231 1.5×	53 0.8×	18 0.4×	61 1.6×	9	391
David Sedwick United States	6	446 1.3×	137 0.9×	63 0.9×	20 0.4×	40 1.1×	7	514

Countries citing papers authored by Michael P. Thomas

Since Specialization

Citations

This map shows the geographic impact of Michael P. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Thomas more than expected).

Fields of papers citing papers by Michael P. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Thomas. The network helps show where Michael P. Thomas may publish in the future.

Co-authorship network of co-authors of Michael P. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Thomas. A scholar is included among the top collaborators of Michael P. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Thomas. Michael P. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Thomas, Michael P., Alexander E. Ivliev, Jesper L.V. Mååg, et al.. (2025). Abstract 1658: REM-422, a first-in-class mRNA degrader of the MYB oncogene, demonstrates anti-tumor activity in xenograft models of adenoid cystic carcinoma and acute myeloid leukemia. Cancer Research. 85(8_Supplement_1). 1658–1658.

2.

Garcia, Khristofer, Jonathan L. Blank, David C. Bouck, et al.. (2014). Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways. Molecular Cancer Therapeutics. 13(6). 1625–1635. 45 indexed citations

3.

Yang, Xiaofeng, James E. Brownell, Qing Xu, et al.. (2013). Absolute Quantification of E1, Ubiquitin-Like Proteins and Nedd8–MLN4924 Adduct by Mass Spectrometry. Cell Biochemistry and Biophysics. 67(1). 139–147. 11 indexed citations

4.

Milhollen, Michael A., Tary Traore, Michael P. Thomas, et al.. (2010). MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB–dependent lymphoma. Blood. 116(9). 1515–1523. 270 indexed citations

5.

Schimmer, Aaron D., Michael P. Thomas, Rose Hurren, et al.. (2006). Identification of Small Molecules that Sensitize Resistant Tumor Cells to Tumor Necrosis Factor-Family Death Receptors. Cancer Research. 66(4). 2367–2375. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact